Comparative Tolerability of Dopamine D2/3 Receptor Partial Agonists for Schizophrenia
Nicholas Keks, Judith Hope, Darren Schwartz, Harold McLennan, David Copolov, Graham Meadows
CNS Drugs | ADIS INT LTD | Published : 2020
The preparation of this review was supported by research funding to NK and JH from the Pratt Foundation. There were no other sources of support.